Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Lynx1 Capital Management LP
Form 13F · Q2 2026

Lynx1 Capital Management LP

CIK 1910456申报日 2026-08-1313F-HR/A 在 EDGAR 查看原始申报 ↗
$8.7亿
申报组合市值
27
持仓数量
12
Quarters on record
Top 50
持仓数量

Lynx1 Capital Management LP——持仓

共 27 个持仓中的前 27 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1GHRS Gh Research Plc13.3M+23.2%$3.6亿41.2%
2CGEM Cullinan Therapeutics Inc9.0M+0.0%$1.6亿18.9%
3STOK Stoke Therapeutics Inc4.0M−15.2%$1.3亿15.3%
4AGIO Agios Pharmaceuticals Inc3.4M+30.5%$1.3亿14.6%
5CCCC C4 Therapeutics Inc7.3M+4.7%$3422万4.0%
6KRRO Korro Bio Inc1.5M+0.0%$2027万2.3%
7TCRX Tscan Therapeutics Inc8.0M+0.0%$786万0.9%
8DTIL Precision Biosciences Inc950,466−3.5%$747万0.9%
9NEUP Neuphoria Therapeutics Inc875,328+0.0%$383万0.4%
10PASG Passage Bio Inc673,759+8.0%$329万0.4%
11CGON Cg Oncology Inc31,391−0.6%$223万0.3%
12PLRX Pliant Therapeutics Inc1.8M—$205万0.2%
13TRDA Entrada Therapeutics Inc178,606−15.6%$131万0.2%
14VYNE THERAPEUTICS INC Vyne Therapeutics Inc1.6M+0.0%$106万0.1%
15PRQR Proqr Thrapeutics N V521,413+661.3%$97万0.1%
16TRAW Traws Pharma Inc559,470+3610.5%$47万0.1%
17FHTX Foghorn Therapeutics Inc61,588—$30万0.0%
18DNLI Denali Therapeutics Inc11,658−99.4%$30万0.0%
19XNCR Xencor Inc18,194−96.6%$29万0.0%
20ABSI Absci Corporation21,245+0.0%$25万0.0%
21HOWL Werewolf Therapeutics Inc657,786+0.0%$24万0.0%
22IMTX Immatics N.V23,236−89.3%$24万0.0%
23AVTX Avalo Therapeutics Inc10,100—$19万0.0%
24BOLT Bolt Biotherapeutics Inc30,800+0.0%$12万0.0%
25NUVB Nuvation Bio Inc16,029—$9万0.0%
26EPRX Eupraxia Pharmaceuticals Inc10,000—$7万0.0%
27IKT Inhibikase Therapeutics Inc20,000—$4万0.0%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。